Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy,
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...
Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback